Cancer Immune Research and Therapy

Dear Colleagues,

The immune system is crucially involved in cancer biology research and plays a major role in minimizing or fix the dysregulation caused by the changes in the surrounding tumor environment. Numerous studies have highlighted the importance of innate and adaptive immunity for resisting changes that occur in normal cellular phenotypes leading to cancerous cell types. Today, not only chemopreventive agents but also immunomodulators and even bacterial toxins have been highlighted to possess therapeutic potential against cancer. However, the identification of immunomodulators and immune targets and their regulators is desirable to identify not only cancer prognostic biomarkers but also valid targets for anticancer therapy. Research studies using these agents in real scenarios with cancer patients are incredibly limited because of ineffective research strategies. Therefore, this Special Issue will cover all aspects involved in therapeutic research and developmental strategies to improve survival and ultimately decrease morbidity in cancer patients. This issue plans to focus on all the aspects involved in cancer immunotherapies with promising agents and approaches that are characterized as ideal candidates against cancer. In this Special Issue, original research articles and reviews are welcome.

Potential topics include but are not limited to:

• Promising phytochemicals against cancers;
• Immunomodulatory response;
• Therapeutic strategies;
• Mechanisms underlying immunological changes;
• Adverse effects of phytochemicals;
• Identification of cancer prognostic biomarkers;
• Combinatorial strategies;
• Future perspectives for phytochemicals.

Dr. Ruchi Roy
Dr. Sunil Singh
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cancer immunology
• cancer chemoprevention
• innate immunity
• adaptive immunity
• adjuvants
• nanotherapeutics
• immunomodulators
• bacterial endotoxins